Vaccines for Infectious Diseases (undisclosed)
Infectious Diseases
Pre-clinicalActive
Key Facts
About Takis
Takis is a private, Rome-based biotech firm operating as both a service provider (CRO) and a therapeutic developer. Its core focus is on discovering and developing novel immunotherapies, primarily therapeutic antibodies and DNA/mRNA vaccines for oncology and infectious diseases. The company possesses over a decade of experience in drug discovery, validated preclinical models, and advanced manufacturing capabilities, positioning it as a specialized partner in the European biotech ecosystem. While it advances its own pipeline candidates towards early-phase trials, its service arm generates revenue through collaborations with pharmaceutical and research clients.
View full company profileTherapeutic Areas
Other Infectious Diseases Drugs
| Drug | Company | Phase |
|---|---|---|
| inPROBE Platform | SDS Optic | Early R&D |
| Potential Human POC Diagnostics | MatMaCorp | Research |
| Nanoparticle Vaccines | Opko Health | Research |
| Platform Vaccine Applications | Chimeron Bio | Discovery |
| FMN riboswitch modulator | Acellera | Pre-clinical |
| NP-G2-044 | Novita Pharmaceuticals | Pre-Clinical |
| Ramoplanin™ | Nanopharmaceutics | Clinical |
| NanoDOX™ | Nanopharmaceutics | Clinical |
| Infectious Diseases | Menarini | Clinical |
| Undisclosed Infectious Disease Program(s) | ATB therapeutics | Pre-clinical |
| Infectious Disease Diagnostics Program | Aptus Biosciences | Discovery |
| Undisclosed Multispecific Therapeutics | ModeX Therapeutics | Pre-clinical |